{"gene":"HTR1A","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":1999,"finding":"The 5-HT1A receptor couples to inhibitory G proteins (Gi/o) to inhibit adenylyl cyclase; transfection of the cloned receptor cDNA into naive cells revealed multiple signal transduction pathways including novel signaling linkages and elucidated mechanisms of receptor desensitization.","method":"Recombinant receptor expression in heterologous cell lines, cAMP/adenylyl cyclase assays, site-directed mutagenesis","journal":"British journal of pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution in heterologous cells, functional assays, mutagenesis, replicated across many labs over a decade","pmids":["10482904"],"is_preprint":false},{"year":1991,"finding":"DMT acts as a full agonist at 5-HT1A receptors, inhibiting forskolin-stimulated adenylate cyclase activity in rat hippocampus with EC50 ~4 µM; GTP sensitivity of radioligand binding confirmed agonist activity.","method":"Radioligand binding with GTP shift, adenylate cyclase assay in rat hippocampal membranes","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro functional assay with biochemical readout, single study","pmids":["1828347"],"is_preprint":false},{"year":2000,"finding":"Methiothepin and spiperone act as inverse agonists at the 5-HT1A receptor, inhibiting both agonist-stimulated and basal [35S]GTPγS binding in CHO cells expressing the receptor; spiperone stabilizes receptor forms uncoupled from G proteins, while methiothepin stabilizes an inactive receptor form that retains G protein coupling.","method":"[35S]GTPγS binding assay in CHO-5-HT1A cells, extended ternary complex model simulation, modulation by GDP and sodium ion concentration","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted receptor in defined cell system, multiple pharmacological conditions, mechanistic modeling","pmids":["10617139"],"is_preprint":false},{"year":2004,"finding":"5-HT1A receptors mediate hyperpolarization of orexin/hypocretin neurons via activation of G protein-coupled inward rectifier potassium (GIRK) channels (single-channel conductance ~33.8 pS); 5-HT1A receptor-like immunoreactivity was detected on orexin neurons and serotonergic nerve endings apposed to orexin neurons.","method":"Patch-clamp electrophysiology (whole-cell and single-channel) in hypothalamic slices from orexin-EGFP transgenic mice, pharmacological blockade with WAY100635, Ba2+ channel blockade, immunohistochemistry","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct electrophysiology with selective pharmacology, single-channel conductance measurement, and immunohistochemical localization in the same study","pmids":["15306649"],"is_preprint":false},{"year":2008,"finding":"The intracellular trafficking protein Yif1B interacts with the C-terminal domain of the 5-HT1A receptor and is required for targeting of the receptor to distal dendrites; siRNA knockdown of Yif1B specifically prevented dendritic addressing of 5-HT1A receptor without affecting other receptors (sst2A, P2X2, 5-HT3A).","method":"Yeast two-hybrid screen using 5-HT1A C-terminal 17 aa as bait, GST pull-down with rat brain extracts and transfected cell lines, co-localization imaging, siRNA knockdown in primary neuron cultures","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — yeast two-hybrid, GST pull-down, reciprocal co-localization, and functional siRNA knockdown with specific dendritic targeting readout in one study","pmids":["18685031"],"is_preprint":false},{"year":1996,"finding":"5-HT1A receptor immunoreactivity is localized to the somatodendritic compartment (dendritic shaft, branches, spines, perikaryon) of raphe neurons and to the axon hillock of cortical and hippocampal pyramidal neurons; astrocytes and other non-neuronal cells also express the receptor.","method":"Immunocytochemistry with antipeptide antibody (aa170-186) in perfusion-fixed primate brain (Macaca fascicularis)","journal":"Neuropsychopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct immunocytochemical localization in primate brain, validated antibody, multiple cell types characterized","pmids":["8719028"],"is_preprint":false},{"year":2019,"finding":"5-HT1A receptor is palmitoylated in human and rodent brains; ZDHHC21 is the major palmitoyl acyltransferase responsible; depletion of ZDHHC21 reduces palmitoylation and signaling functions of 5-HT1AR; miR-30e negatively regulates ZDHHC21 expression; reduced 5-HT1AR palmitoylation and ZDHHC21 expression were found in post-mortem prefrontal cortex of MDD suicides.","method":"Palmitoylation assays in brain tissue and cell lines, siRNA knockdown of ZDHHC21, palmitoylation-deficient mutant, microRNA analysis, post-mortem human brain analysis, behavioral assays in mice with forebrain-specific ZDHHC21 knockdown","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal biochemical methods (palmitoylation assay, mutagenesis, KD), in vivo behavioral validation, human post-mortem replication in single study","pmids":["31477731"],"is_preprint":false},{"year":2008,"finding":"5-HT1A receptors form specific homo-oligomers at the plasma membrane of living cells, as demonstrated by FRET between CFP- and YFP-tagged receptors; palmitoylation promotes receptor localization to lipid-rich microdomains and increases effective surface density, thereby facilitating oligomerization — a palmitoylation-deficient mutant showed reduced FRET efficiency.","method":"2-excitation FRET with spectral microscopy in living cells, CFP/YFP-tagged 5-HT1A receptors, palmitoylation-deficient mutant analysis","journal":"Glycoconjugate journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live-cell FRET with quantitative analysis and mutagenesis, single lab","pmids":["18853255"],"is_preprint":false},{"year":2014,"finding":"5-HT1A and 5-HT7 receptors form homo- and heterodimers both in vitro and in vivo; heterodimerization plays a role in regulation of receptor-mediated signaling and internalization.","method":"Co-immunoprecipitation and FRET-based dimerization assays in vitro and in vivo (as described in cited review citing primary data)","journal":"CNS neuroscience & therapeutics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — described in a review citing primary work; abstract does not detail the specific experimental methods used to establish dimerization","pmids":["24935787"],"is_preprint":false},{"year":2004,"finding":"5-HT2A receptor activation in the hypothalamic paraventricular nucleus (PVN) induces heterologous desensitization of 5-HT1A receptors within individual neuroendocrine cells; 5-HT1A and 5-HT2A receptors are colocalized in oxytocin and CRF neurons of the PVN; microinjection of 5-HT2A antagonist MDL100,907 prevented desensitization.","method":"In vivo neuroendocrine functional assay (oxytocin and ACTH responses to 8-OH-DPAT), microinjection of 5-HT2A antagonist into PVN, double-label immunocytochemistry","journal":"The Journal of pharmacology and experimental therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo pharmacological epistasis combined with anatomical colocalization, single lab","pmids":["15064330"],"is_preprint":false},{"year":2010,"finding":"Mice engineered with higher 5-HT1A autoreceptor levels in raphe nuclei (1A-High) show robustly increased raphe firing rate inhibition, increased behavioral despair, and no behavioral response to antidepressants, establishing a causal relationship between 5-HT1A autoreceptor level, raphe firing, stress resilience, and antidepressant response.","method":"Genetic mouse models selectively manipulating raphe 5-HT1A autoreceptors; electrophysiological recording of raphe firing; in vivo microdialysis; behavioral testing; antidepressant response assays","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — selective genetic manipulation in vivo, electrophysiology, microdialysis, behavioral readouts, and rescue experiment in single rigorous study","pmids":["20152112"],"is_preprint":false},{"year":2012,"finding":"Acute siRNA-mediated knockdown of 5-HT1A autoreceptors in the dorsal raphe nucleus reduces receptor mRNA and binding, abolishes 8-OH-DPAT-induced hypothermia, and increases prefrontal 5-HT release during stress, producing antidepressant-like effects and augmenting fluoxetine-evoked 5-HT release.","method":"Stereotaxic intra-DRN siRNA infusion, in situ hybridization, receptor binding, in vivo microdialysis, behavioral tests (tail suspension, forced swim), 8-OH-DPAT-induced hypothermia","journal":"Psychopharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (molecular, neurochemical, behavioral) in single study with appropriate controls including 5-HT1A KO mice","pmids":["22820867"],"is_preprint":false},{"year":1993,"finding":"Adrenal corticosteroids selectively regulate hippocampal 5-HT1A receptor expression; adrenalectomy increases 5-HT1A receptor mRNA and binding throughout the hippocampus, and exogenous corticosterone replacement restores levels to sham values.","method":"In situ hybridization for 5-HT1A mRNA, in vitro receptor autoradiography with [3H]8-OH-DPAT, adrenalectomy and corticosterone replacement in rats","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — parallel mRNA and binding measurements with bidirectional pharmacological manipulation (ADX + CORT rescue), multiple hippocampal subfields, two time-points","pmids":["8441016"],"is_preprint":false},{"year":2004,"finding":"The C(-1019)G (rs6295) polymorphism in the HTR1A promoter selectively blocks repression by the transcription factors NUDR/Deaf-1, Hes1, and Hes5 at the autoreceptor locus, resulting in increased 5-HT1A autoreceptor expression in raphe neurons.","method":"Promoter-reporter assays in neuronal cell lines, transcription factor binding studies, in vitro and in vivo allele-specific repression assays","journal":"The Neuroscientist","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell culture reporter assays and transcription factor binding established mechanism; described in a review but citing multiple primary experiments from same group","pmids":["15534042"],"is_preprint":false},{"year":2008,"finding":"HES1 strongly represses 5-HT1A receptor transcription via a consensus HES site in the promoter, including at the G(-1019) allele (unlike HES5); HES6 reverses HES1- and HES5-mediated repression; HES1 knockout mice show elevated 5-HT1A receptor RNA and protein in hindbrain and midbrain at E12.5, establishing HES1 as required for correct developmental expression.","method":"Promoter-reporter assays in neuronal and non-neuronal cells, site-directed mutagenesis of HES consensus site, HES1−/− mouse embryos analyzed by in situ hybridization and immunohistochemistry","journal":"Molecular and cellular neurosciences","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis of functional element, genetic KO validation in vivo, multiple cell types, two orthogonal readouts (mRNA and protein)","pmids":["18499474"],"is_preprint":false},{"year":2003,"finding":"BDNF deficiency (heterozygous BDNF +/− mice) attenuates 5-HT1A receptor-stimulated [35S]GTPγS binding in the median and dorsal raphe nucleus and hippocampus without changing receptor number, indicating that BDNF regulates 5-HT1A receptor–G protein coupling efficiency.","method":"Agonist-stimulated [35S]GTPγS binding autoradiography, radioligand binding for receptor number, two-bottle choice ethanol intake in BDNF +/− vs WT mice","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional G-protein coupling assay dissociating from receptor number, genetic model, multiple brain regions","pmids":["12753073"],"is_preprint":false},{"year":2021,"finding":"HTR1A antagonism (WAY-100635) in GT1-7 GnRH neuronal cells upregulates GnRH expression by reducing CBX4 (a PRC1 component) expression, decreasing H2AK119 ubiquitination at the GnRH promoter, and degrading the PRC1 complex; this is mediated through suppression of PI3K/Akt and MAPK/ERK pathways.","method":"RNA-seq, ChIP-seq for CBX4 and H2AK119ub, co-immunoprecipitation (RING2, YY1, CBX4 interaction), pharmacological treatment of GT1-7 cells with WAY-100635","journal":"Molecular therapy. Nucleic acids","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq and Co-IP in defined cell line, multiple orthogonal molecular methods, single lab","pmids":["34458005"],"is_preprint":false},{"year":2022,"finding":"HTR1A interacts with TRIM21 and PSMD7 to inhibit ubiquitin-proteasome-dependent degradation of TGF-β receptor II (TβRII), thereby suppressing both canonical and noncanonical TGF-β signaling pathways in triple-negative breast cancer cells.","method":"Co-immunoprecipitation assays, RNA-seq, siRNA knockdown, in vivo and in vitro functional experiments in breast cancer models","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP identifying interacting partners, RNA-seq, functional KD, single lab","pmids":["35199941"],"is_preprint":false},{"year":1990,"finding":"5-HT1A receptor agonists inhibit the firing rate of 5-HT-containing dorsal raphe neurons and inhibit cortical/hippocampal 5-HT synthesis via presynaptic somatodendritic autoreceptors; postsynaptic 5-HT1A receptors are negatively coupled to adenylyl cyclase.","method":"Electrophysiology (in vitro and in vivo raphe neuron firing), neurochemical assays of 5-HT synthesis inhibition, adenylyl cyclase functional assays","journal":"Journal of clinical psychopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional readouts (electrophysiology + neurochemistry), replicated across labs in same era","pmids":["1973941"],"is_preprint":false},{"year":2018,"finding":"5-HT1A receptor coupled primarily to Gi3 in 5-HT neurons and to Gi2 in hippocampal neurons; Gβγ subunit-mediated signaling opens potassium channels and closes calcium channels to reduce neuronal activity; in hippocampal neurons (but not 5-HT neurons), 5-HT1A receptor signals to activate ERK1/2 and can also engage ACII, PLC/PKC, CaMKII, and PI3K/Akt pathways through Gβγ and tyrosine kinase receptor crosstalk.","method":"G protein coupling studies in neuronal cell lines and primary neurons, signaling pathway assays (ERK, PI3K/Akt, CAMKII), ion channel recordings; review compiling primary experimental data","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — review synthesizing multiple primary experiments from several labs; individual pathway findings are tier 1–2 but assessed collectively from a review abstract","pmids":["31079617"],"is_preprint":false},{"year":2015,"finding":"5-HT1A autoreceptors in the dorsal raphe nucleus are necessary for cocaine conditioned place preference; inhibition of dorsal raphe 5-HT1A autoreceptors attenuates compulsive cocaine self-administration in rats with extended (6 h) but not limited (1 h) access.","method":"5-HT neuron-specific 5-HT1A autoreceptor gene knockdown (conditional KO), DREADD-mediated stimulation of DRN→NAc serotonergic projections, rat cocaine self-administration model","journal":"Neuropsychopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific genetic manipulation and chemogenetics with defined behavioral readouts, single lab","pmids":["26324408"],"is_preprint":false},{"year":2005,"finding":"5-HT1A receptor protein expression in the developing rat hippocampus begins at initial stages of embryonic development, is concentrated around cell bodies before distributing to dendrites as neurons mature, and is transiently expressed in S100/GFAP-positive glia during early postnatal development.","method":"Immunohistochemistry with validated anti-5-HT1A antibody in developing rat hippocampus from embryonic to early postnatal stages","journal":"Brain research. Developmental brain research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct immunohistochemical localization with developmental time course, validated antibody, multiple cell types","pmids":["15939084"],"is_preprint":false},{"year":2019,"finding":"Rotigotine stimulates astrocyte 5-HT1A receptors to increase astrocyte proliferation and upregulate metallothionein (MT)-1,2 expression; conditioned medium from rotigotine-treated astrocytes protects dopaminergic neurons from 6-OHDA toxicity; these effects were completely blocked by a 5-HT1A antagonist or MT-1,2 antibody in vitro and in vivo.","method":"Primary astrocyte cultures, conditioned medium experiments, 5-HT1A antagonist blockade, MT-1,2 antibody neutralization, subcutaneous rotigotine in 6-OHDA mouse model with immunohistochemistry","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo pharmacological blockade with defined molecular readout (MT expression), single lab","pmids":["31765686"],"is_preprint":false},{"year":1998,"finding":"Stimulation of postsynaptic (not presynaptic) 5-HT1A receptors impairs passive avoidance retention in rats; the memory deficit is blocked by selective 5-HT1A antagonists but not 5-HT2A/2C antagonists or beta-blockers; 5-HT1A receptor stimulation interferes with both acquisition and retrieval phases of learning.","method":"Step-through passive avoidance test in rats, selective pharmacological agonists and antagonists (WAY 100135, ketanserin, alprenolol), state-dependent learning paradigm, tryptophan depletion (PCPA)","journal":"British journal of pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple pharmacological dissections with receptor-selective tools and behavioral readouts, single lab","pmids":["9806333"],"is_preprint":false}],"current_model":"HTR1A (5-HT1A) is a Gi/o-coupled GPCR that functions as both a somatodendritic autoreceptor on raphe 5-HT neurons — where Gi3-mediated inhibition of adenylyl cyclase and Gβγ-dependent opening of GIRK channels suppress neuronal firing — and as a postsynaptic heteroreceptor in limbic and cortical regions, where Gi2 coupling additionally activates ERK1/2, PI3K/Akt, and CaMKII pathways; its dendritic targeting requires interaction with the trafficking protein Yif1B; its activity is modulated by ZDHHC21-mediated palmitoylation, by corticosteroid-regulated transcription, and by transcription factors HES1/HES5/Deaf-1 acting at the functional C(-1019)G promoter polymorphism to differentially regulate autoreceptor versus heteroreceptor expression levels, with autoreceptor-level control causally determining raphe firing rate, stress resilience, and antidepressant response."},"narrative":{"mechanistic_narrative":"HTR1A (5-HT1A) is a Gi/o-coupled serotonin receptor that suppresses neuronal activity, serving both as a somatodendritic autoreceptor on raphe serotonergic neurons and as a postsynaptic heteroreceptor in cortical, hippocampal, and hypothalamic circuits [PMID:10482904, PMID:1973941]. The receptor couples to inhibitory G proteins to inhibit adenylyl cyclase, and its activation hyperpolarizes neurons by opening G protein-coupled inwardly rectifying potassium (GIRK) channels [PMID:15306649], reducing the firing of dorsal raphe 5-HT neurons and limiting forebrain 5-HT synthesis [PMID:1973941]. Coupling is region-selective — Gi3 in 5-HT neurons versus Gi2 in hippocampal neurons — with Gβγ-driven ion channel modulation reducing excitability and, in hippocampal neurons, additional engagement of ERK1/2 and PI3K/Akt signaling [PMID:31079617]. Receptor pharmacology spans full agonism, inverse agonism that stabilizes G-protein-uncoupled or inactive states, and ligand-dependent control of the ternary complex [PMID:1828347, PMID:10617139]. Spatial deployment of the receptor is actively controlled: the C-terminus binds the trafficking protein Yif1B, which is required for dendritic targeting [PMID:18685031], while ZDHHC21-mediated palmitoylation supports signaling competence and partitioning into lipid microdomains that promote receptor homo-oligomerization [PMID:31477731, PMID:18853255]. Expression is set transcriptionally by Deaf-1/HES1/HES5 repressors acting at the promoter, where the C(-1019)G polymorphism relieves autoreceptor repression and elevates raphe receptor levels [PMID:15534042, PMID:18499474], and by corticosteroid regulation of hippocampal expression [PMID:8441016]. Autoreceptor abundance is causally determinative: genetically elevated raphe autoreceptor levels increase firing inhibition, behavioral despair, and antidepressant resistance, whereas autoreceptor knockdown elevates prefrontal 5-HT release and produces antidepressant-like effects [PMID:20152112, PMID:22820867]. Beyond neuronal signaling, HTR1A also acts in non-neuronal contexts, stabilizing TGF-β receptor II against proteasomal degradation in breast cancer cells [PMID:35199941] and, in serotonergic and GnRH cell models, regulating gene expression through PI3K/Akt and MAPK/ERK pathways [PMID:34458005].","teleology":[{"year":1990,"claim":"Established the core physiological dichotomy: 5-HT1A acts as a somatodendritic autoreceptor inhibiting raphe firing and 5-HT synthesis, and as a postsynaptic receptor negatively coupled to adenylyl cyclase, defining the receptor's two-compartment role.","evidence":"Electrophysiology of raphe neuron firing, neurochemical 5-HT synthesis assays, and adenylyl cyclase assays","pmids":["1973941"],"confidence":"Medium","gaps":["Did not resolve which Gi/o isoforms mediate each compartment","Mechanism of receptor desensitization not addressed"]},{"year":1991,"claim":"Demonstrated functional agonist coupling by showing a ligand inhibits forskolin-stimulated adenylate cyclase with GTP-sensitive binding, confirming the Gi-linked cyclase-inhibitory readout in native tissue.","evidence":"Radioligand binding with GTP shift and adenylate cyclase assay in rat hippocampal membranes","pmids":["1828347"],"confidence":"Medium","gaps":["Single agonist tested in one tissue","No downstream pathway beyond cAMP examined"]},{"year":1993,"claim":"Revealed that receptor expression is not static but set by endocrine state, with corticosteroids bidirectionally regulating hippocampal 5-HT1A mRNA and binding.","evidence":"In situ hybridization and receptor autoradiography with adrenalectomy and corticosterone replacement in rats","pmids":["8441016"],"confidence":"High","gaps":["Transcription factors mediating corticosteroid effect not identified","Effect on raphe autoreceptors versus heteroreceptors not distinguished"]},{"year":1996,"claim":"Mapped the subcellular distribution underlying the autoreceptor/heteroreceptor distinction, placing the receptor in the somatodendritic compartment of raphe neurons and the axon hillock of pyramidal neurons.","evidence":"Immunocytochemistry with antipeptide antibody in primate brain","pmids":["8719028"],"confidence":"Medium","gaps":["Trafficking mechanism producing compartment-specific localization unknown","Functional consequence of astrocytic expression unaddressed"]},{"year":1999,"claim":"Reconstituted the cloned receptor in heterologous cells to define Gi/o coupling, multiple downstream signaling linkages, and desensitization mechanisms independent of neuronal context.","evidence":"Recombinant expression in cell lines, cAMP assays, site-directed mutagenesis","pmids":["10482904"],"confidence":"High","gaps":["Did not map G-protein isoform specificity by neuron type","Endogenous neuronal partners not captured in heterologous system"]},{"year":2000,"claim":"Distinguished classes of antagonist behavior at the receptor, showing inverse agonists suppress basal G-protein activity and stabilize distinct receptor conformations within the ternary complex.","evidence":"[35S]GTPγS binding in CHO-5-HT1A cells with ternary complex modeling and ion modulation","pmids":["10617139"],"confidence":"High","gaps":["Structural basis of the stabilized conformations not resolved","In vivo relevance of constitutive activity untested"]},{"year":2003,"claim":"Showed that receptor signaling efficiency is regulated by a neurotrophin, as BDNF deficiency reduces 5-HT1A–G protein coupling without altering receptor number.","evidence":"Agonist-stimulated [35S]GTPγS binding autoradiography and radioligand binding in BDNF +/− mice","pmids":["12753073"],"confidence":"Medium","gaps":["Molecular link between BDNF signaling and coupling efficiency unidentified","Behavioral consequence of altered coupling not isolated"]},{"year":2004,"claim":"Resolved the ion-channel effector for inhibition, demonstrating 5-HT1A hyperpolarizes target neurons by activating GIRK channels with defined single-channel conductance.","evidence":"Patch-clamp electrophysiology in orexin neurons with selective pharmacology and immunohistochemistry","pmids":["15306649"],"confidence":"High","gaps":["Gβγ versus Gα contribution to channel gating not dissected here","Limited to one neuronal population"]},{"year":2004,"claim":"Demonstrated cross-receptor regulation, with 5-HT2A activation causing heterologous desensitization of co-localized 5-HT1A receptors within single neuroendocrine cells.","evidence":"In vivo neuroendocrine assays with intra-PVN 5-HT2A antagonist microinjection and double-label immunocytochemistry","pmids":["15064330"],"confidence":"Medium","gaps":["Intracellular signaling mediating cross-desensitization unidentified","Restricted to PVN neuroendocrine cells"]},{"year":2004,"claim":"Identified the transcriptional basis of the disease-associated promoter variant, showing C(-1019)G blocks Deaf-1/Hes repression to raise autoreceptor expression.","evidence":"Promoter-reporter assays and transcription factor binding studies in neuronal cell lines","pmids":["15534042"],"confidence":"Medium","gaps":["Allele-specific effects on heteroreceptors versus autoreceptors not fully separated","In vivo human consequences inferred"]},{"year":2005,"claim":"Characterized the developmental trajectory of receptor expression, from perinuclear localization in immature neurons to dendritic distribution with maturation, plus transient glial expression.","evidence":"Immunohistochemistry across embryonic to postnatal rat hippocampus","pmids":["15939084"],"confidence":"Medium","gaps":["Mechanism driving the perinuclear-to-dendritic shift not defined","Function of transient glial expression unknown"]},{"year":2008,"claim":"Identified Yif1B as the C-terminal-binding trafficking partner required specifically for dendritic targeting, providing a molecular basis for compartment-specific receptor delivery.","evidence":"Yeast two-hybrid, GST pull-down, co-localization, and siRNA knockdown in primary neurons","pmids":["18685031"],"confidence":"High","gaps":["How Yif1B selects 5-HT1A over other cargo unresolved","Role in raphe autoreceptor targeting not directly tested"]},{"year":2008,"claim":"Showed the receptor self-associates into plasma-membrane homo-oligomers and that palmitoylation promotes oligomerization via lipid-microdomain partitioning.","evidence":"Live-cell 2-excitation FRET with CFP/YFP-tagged receptors and palmitoylation-deficient mutant","pmids":["18853255"],"confidence":"Medium","gaps":["Functional consequence of oligomerization for signaling not established","Single-lab live-cell FRET"]},{"year":2008,"claim":"Established HES1 as a developmental repressor of receptor transcription required in vivo, acting at a promoter consensus site including the G(-1019) allele, with HES6 relieving repression.","evidence":"Promoter-reporter assays, mutagenesis of HES site, and HES1−/− mouse embryo analysis","pmids":["18499474"],"confidence":"High","gaps":["Adult versus developmental contributions of HES1 not separated","Interplay with corticosteroid regulation untested"]},{"year":2010,"claim":"Established causality between autoreceptor level and behavior, with genetically elevated raphe autoreceptors increasing firing inhibition, despair, and antidepressant resistance.","evidence":"Genetic mouse models with selective raphe autoreceptor manipulation, electrophysiology, microdialysis, and behavior","pmids":["20152112"],"confidence":"High","gaps":["Did not test acute, reversible manipulation","Heteroreceptor contribution held separate but not co-varied"]},{"year":2012,"claim":"Confirmed the autoreceptor as a therapeutic lever, showing acute DRN autoreceptor knockdown increases prefrontal 5-HT release and produces antidepressant-like effects that augment fluoxetine.","evidence":"Intra-DRN siRNA, in situ hybridization, microdialysis, and behavioral tests with 5-HT1A KO controls","pmids":["22820867"],"confidence":"High","gaps":["Durability of knockdown effect not assessed","Effect on heteroreceptor-mediated responses not measured"]},{"year":2015,"claim":"Extended autoreceptor function to addiction circuitry, showing DRN 5-HT1A autoreceptors are necessary for cocaine place preference and compulsive self-administration under extended access.","evidence":"5-HT-neuron-specific conditional knockdown, DREADD stimulation of DRN→NAc projections, rat self-administration","pmids":["26324408"],"confidence":"Medium","gaps":["Downstream NAc circuit mechanism not resolved","Single-lab behavioral model"]},{"year":2018,"claim":"Resolved region-specific G-protein coupling (Gi3 in 5-HT neurons, Gi2 in hippocampal neurons) and the downstream divergence into ion-channel inhibition versus ERK/PI3K-Akt/CaMKII signaling.","evidence":"Compiled G-protein coupling, signaling pathway assays, and ion channel recordings across neuronal systems","pmids":["31079617"],"confidence":"Medium","gaps":["Determinants of isoform-selective coupling unknown","Synthesized from multiple primary sources"]},{"year":2019,"claim":"Identified ZDHHC21 as the palmitoyl acyltransferase controlling receptor signaling competence, linked reduced palmitoylation to MDD pathology and to miR-30e regulation.","evidence":"Palmitoylation assays, ZDHHC21 knockdown, palmitoylation-deficient mutant, post-mortem human cortex, and behavior in forebrain ZDHHC21-knockdown mice","pmids":["31477731"],"confidence":"High","gaps":["Causal direction of palmitoylation changes in human MDD not established","Effect on autoreceptor versus heteroreceptor pools not separated"]},{"year":2019,"claim":"Defined a neuroprotective astrocytic function, with astrocyte 5-HT1A stimulation driving metallothionein upregulation and dopaminergic neuroprotection.","evidence":"Primary astrocyte cultures, conditioned-medium and antibody-neutralization experiments, and 6-OHDA mouse model","pmids":["31765686"],"confidence":"Medium","gaps":["Signaling pathway from astrocyte 5-HT1A to MT induction not mapped","Single-lab pharmacological model"]},{"year":2021,"claim":"Showed receptor signaling controls epigenetic gene regulation, as HTR1A antagonism upregulates GnRH by destabilizing PRC1/CBX4 and reducing H2AK119 ubiquitination through PI3K/Akt and MAPK/ERK suppression.","evidence":"RNA-seq, ChIP-seq, and Co-IP with WAY-100635 treatment in GT1-7 GnRH neuronal cells","pmids":["34458005"],"confidence":"Medium","gaps":["In vivo relevance of GnRH regulation untested","Single cell line"]},{"year":2022,"claim":"Uncovered a non-canonical, signaling-independent scaffolding role, with HTR1A binding TRIM21 and PSMD7 to protect TGF-β receptor II from proteasomal degradation in breast cancer.","evidence":"Co-IP, RNA-seq, siRNA knockdown, and in vivo/in vitro breast cancer functional assays","pmids":["35199941"],"confidence":"Medium","gaps":["Whether G-protein signaling contributes to this role unknown","Single-lab cancer model"]},{"year":null,"claim":"How transcriptional control, palmitoylation, trafficking, and oligomerization are integrated to set the autoreceptor/heteroreceptor balance in vivo, and how this balance governs antidepressant response in humans, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking post-translational and transcriptional control to compartment-specific receptor pools","Causal human validation of autoreceptor-level effects on treatment response lacking","Structural basis of region-specific G-protein selectivity unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,18,19]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,17]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,7,5]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[4,5]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[16]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,18,19]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[3,10,18]}],"complexes":["5-HT1A homo-oligomer","5-HT1A/5-HT7 heterodimer"],"partners":["YIF1B","ZDHHC21","HTR7","TRIM21","PSMD7","HES1","DEAF1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P08908","full_name":"5-hydroxytryptamine receptor 1A","aliases":["G-21","Serotonin receptor 1A"],"length_aa":422,"mass_kda":46.1,"function":"G-protein coupled receptor for 5-hydroxytryptamine (serotonin) (PubMed:22957663, PubMed:3138543, PubMed:33762731, PubMed:37935376, PubMed:37935377, PubMed:8138923, PubMed:8393041). Also functions as a receptor for various drugs and psychoactive substances (PubMed:22957663, PubMed:3138543, PubMed:33762731, PubMed:38552625, PubMed:8138923, PubMed:8393041). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as adenylate cyclase (PubMed:22957663, PubMed:3138543, PubMed:33762731, PubMed:8138923, PubMed:8393041). HTR1A is coupled to G(i)/G(o) G alpha proteins and mediates inhibitory neurotransmission: signaling inhibits adenylate cyclase activity and activates a phosphatidylinositol-calcium second messenger system that regulates the release of Ca(2+) ions from intracellular stores (PubMed:33762731, PubMed:35610220). Beta-arrestin family members regulate signaling by mediating both receptor desensitization and resensitization processes (PubMed:18476671, PubMed:20363322, PubMed:20945968). Plays a role in the regulation of 5-hydroxytryptamine release and in the regulation of dopamine and 5-hydroxytryptamine metabolism (PubMed:18476671, PubMed:20363322, PubMed:20945968). Plays a role in the regulation of dopamine and 5-hydroxytryptamine levels in the brain, and thereby affects neural activity, mood and behavior (PubMed:18476671, PubMed:20363322, PubMed:20945968). Plays a role in the response to anxiogenic stimuli (PubMed:18476671, PubMed:20363322, PubMed:20945968)","subcellular_location":"Cell membrane; Cell projection, dendrite","url":"https://www.uniprot.org/uniprotkb/P08908/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HTR1A","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HTR1A","total_profiled":1310},"omim":[{"mim_id":"619109","title":"YIP1-INTERACTING FACTOR HOMOLOG B, MEMBRANE-TRAFFICKING PROTEIN; YIF1B","url":"https://www.omim.org/entry/619109"},{"mim_id":"617231","title":"PHOSPHOLYSINE PHOSPHOHISTIDINE INORGANIC PYROPHOSPHATE PHOSPHATASE; LHPP","url":"https://www.omim.org/entry/617231"},{"mim_id":"614674","title":"PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT","url":"https://www.omim.org/entry/614674"},{"mim_id":"600665","title":"MELATONIN RECEPTOR 1A; MTNR1A","url":"https://www.omim.org/entry/600665"},{"mim_id":"312861","title":"5-@HYDROXYTRYPTAMINE RECEPTOR 2C; HTR2C","url":"https://www.omim.org/entry/312861"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":6.1}],"url":"https://www.proteinatlas.org/search/HTR1A"},"hgnc":{"alias_symbol":["5-HT1A"],"prev_symbol":["ADRB2RL1","ADRBRL1"]},"alphafold":{"accession":"P08908","domains":[{"cath_id":"1.20.1070.10","chopping":"31-236_327-419","consensus_level":"high","plddt":91.7875,"start":31,"end":419}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P08908","model_url":"https://alphafold.ebi.ac.uk/files/AF-P08908-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P08908-F1-predicted_aligned_error_v6.png","plddt_mean":77.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HTR1A","jax_strain_url":"https://www.jax.org/strain/search?query=HTR1A"},"sequence":{"accession":"P08908","fasta_url":"https://rest.uniprot.org/uniprotkb/P08908.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P08908/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P08908"}},"corpus_meta":[{"pmid":"12559651","id":"PMC_12559651","title":"Is there a role for 5-HT1A agonists in the treatment of depression?","date":"2003","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/12559651","citation_count":440,"is_preprint":false},{"pmid":"8539333","id":"PMC_8539333","title":"5-HT1A receptor agonists: recent developments and controversial issues.","date":"1995","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8539333","citation_count":414,"is_preprint":false},{"pmid":"15309042","id":"PMC_15309042","title":"The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.","date":"2004","source":"Journal of psychiatry & neuroscience : JPN","url":"https://pubmed.ncbi.nlm.nih.gov/15309042","citation_count":367,"is_preprint":false},{"pmid":"20152112","id":"PMC_20152112","title":"5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants.","date":"2010","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/20152112","citation_count":346,"is_preprint":false},{"pmid":"17316955","id":"PMC_17316955","title":"Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors.","date":"2007","source":"Progress in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/17316955","citation_count":251,"is_preprint":false},{"pmid":"2145593","id":"PMC_2145593","title":"Do functional relationships exist between 5-HT1A and 5-HT2 receptors?","date":"1990","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/2145593","citation_count":238,"is_preprint":false},{"pmid":"8719028","id":"PMC_8719028","title":"Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells.","date":"1996","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8719028","citation_count":225,"is_preprint":false},{"pmid":"15534042","id":"PMC_15534042","title":"5-HT1A receptors, gene repression, and depression: guilt by association.","date":"2004","source":"The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15534042","citation_count":221,"is_preprint":false},{"pmid":"8441016","id":"PMC_8441016","title":"Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression.","date":"1993","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8441016","citation_count":211,"is_preprint":false},{"pmid":"10482904","id":"PMC_10482904","title":"The recombinant 5-HT1A receptor: G protein coupling and signalling pathways.","date":"1999","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10482904","citation_count":209,"is_preprint":false},{"pmid":"11723272","id":"PMC_11723272","title":"Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models.","date":"2001","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11723272","citation_count":200,"is_preprint":false},{"pmid":"11277607","id":"PMC_11277607","title":"The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?","date":"2001","source":"Journal of psychopharmacology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11277607","citation_count":183,"is_preprint":false},{"pmid":"20363322","id":"PMC_20363322","title":"5-HT1A receptor-regulated signal transduction pathways in brain.","date":"2010","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/20363322","citation_count":181,"is_preprint":false},{"pmid":"8122313","id":"PMC_8122313","title":"Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents.","date":"1993","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/8122313","citation_count":176,"is_preprint":false},{"pmid":"12559389","id":"PMC_12559389","title":"Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration.","date":"2003","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/12559389","citation_count":163,"is_preprint":false},{"pmid":"31079617","id":"PMC_31079617","title":"The 5-HT1A receptor: Signaling to behavior.","date":"2018","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/31079617","citation_count":161,"is_preprint":false},{"pmid":"15306649","id":"PMC_15306649","title":"Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor.","date":"2004","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15306649","citation_count":161,"is_preprint":false},{"pmid":"26851834","id":"PMC_26851834","title":"The 5-HT1A receptor in Major Depressive Disorder.","date":"2016","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26851834","citation_count":158,"is_preprint":false},{"pmid":"18639564","id":"PMC_18639564","title":"Transcriptional regulation at a HTR1A polymorphism associated with mental illness.","date":"2008","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18639564","citation_count":141,"is_preprint":false},{"pmid":"12600709","id":"PMC_12600709","title":"5-HT1A receptor knockout mouse as a genetic model of anxiety.","date":"2003","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12600709","citation_count":136,"is_preprint":false},{"pmid":"15469667","id":"PMC_15469667","title":"Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology.","date":"2004","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15469667","citation_count":126,"is_preprint":false},{"pmid":"21619616","id":"PMC_21619616","title":"Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness.","date":"2011","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/21619616","citation_count":121,"is_preprint":false},{"pmid":"1763190","id":"PMC_1763190","title":"5-HT1A receptor responsivity in anxiety disorders and depression.","date":"1991","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/1763190","citation_count":120,"is_preprint":false},{"pmid":"19124686","id":"PMC_19124686","title":"Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety.","date":"2009","source":"Archives of general psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19124686","citation_count":120,"is_preprint":false},{"pmid":"22826341","id":"PMC_22826341","title":"Transcriptional regulation of the 5-HT1A receptor: implications for mental illness.","date":"2012","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22826341","citation_count":119,"is_preprint":false},{"pmid":"20571976","id":"PMC_20571976","title":"The importance of 5-HT1A receptor agonism in antipsychotic drug action: rationale and perspectives.","date":"2010","source":"Current opinion in investigational drugs (London, England : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/20571976","citation_count":114,"is_preprint":false},{"pmid":"12753073","id":"PMC_12753073","title":"Ethanol consumption and serotonin-1A (5-HT1A) receptor function in heterozygous BDNF (+/-) mice.","date":"2003","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12753073","citation_count":114,"is_preprint":false},{"pmid":"12404340","id":"PMC_12404340","title":"5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response.","date":"2000","source":"Human psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12404340","citation_count":110,"is_preprint":false},{"pmid":"8719026","id":"PMC_8719026","title":"The 5-HT1A receptor: signaling, desensitization, and gene transcription.","date":"1996","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8719026","citation_count":104,"is_preprint":false},{"pmid":"10440734","id":"PMC_10440734","title":"Anxiety and increased 5-HT1A receptor response in NCAM null mutant mice.","date":"1999","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/10440734","citation_count":103,"is_preprint":false},{"pmid":"8199791","id":"PMC_8199791","title":"5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone.","date":"1994","source":"The British journal of psychiatry : the journal of mental science","url":"https://pubmed.ncbi.nlm.nih.gov/8199791","citation_count":95,"is_preprint":false},{"pmid":"24935787","id":"PMC_24935787","title":"Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders.","date":"2014","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/24935787","citation_count":94,"is_preprint":false},{"pmid":"31477731","id":"PMC_31477731","title":"Attenuated palmitoylation of serotonin receptor 5-HT1A affects receptor function and contributes to depression-like behaviors.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31477731","citation_count":93,"is_preprint":false},{"pmid":"17408646","id":"PMC_17408646","title":"Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C.","date":"2007","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/17408646","citation_count":84,"is_preprint":false},{"pmid":"7984351","id":"PMC_7984351","title":"5-HT1A receptor influences on rodent social and agonistic behavior: a review and empirical study.","date":"1994","source":"Neuroscience and biobehavioral reviews","url":"https://pubmed.ncbi.nlm.nih.gov/7984351","citation_count":84,"is_preprint":false},{"pmid":"1346719","id":"PMC_1346719","title":"5-HT1A receptor-effector system responsivity in panic disorder.","date":"1992","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1346719","citation_count":83,"is_preprint":false},{"pmid":"26696889","id":"PMC_26696889","title":"Hippocampal 5-HT1A Receptor and Spatial Learning and Memory.","date":"2015","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26696889","citation_count":82,"is_preprint":false},{"pmid":"15023569","id":"PMC_15023569","title":"Decreased 5-HT1A receptor binding in amygdala of schizophrenia.","date":"2004","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15023569","citation_count":82,"is_preprint":false},{"pmid":"18484082","id":"PMC_18484082","title":"Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder.","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18484082","citation_count":82,"is_preprint":false},{"pmid":"17401528","id":"PMC_17401528","title":"Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression.","date":"2007","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/17401528","citation_count":76,"is_preprint":false},{"pmid":"18691130","id":"PMC_18691130","title":"5-HT1A receptor, an old target for new therapeutic agents.","date":"2008","source":"Current topics in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18691130","citation_count":74,"is_preprint":false},{"pmid":"15064330","id":"PMC_15064330","title":"Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo.","date":"2004","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/15064330","citation_count":69,"is_preprint":false},{"pmid":"15683551","id":"PMC_15683551","title":"Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics.","date":"2004","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15683551","citation_count":68,"is_preprint":false},{"pmid":"15947971","id":"PMC_15947971","title":"5-HT1A receptor expression in pyramidal neurons of cortical and limbic brain regions.","date":"2005","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/15947971","citation_count":66,"is_preprint":false},{"pmid":"17192951","id":"PMC_17192951","title":"HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17192951","citation_count":64,"is_preprint":false},{"pmid":"8028227","id":"PMC_8028227","title":"Antiemetic effects of serotonergic 5-HT1A-receptor agonists in Suncus murinus.","date":"1994","source":"Japanese journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8028227","citation_count":64,"is_preprint":false},{"pmid":"22820867","id":"PMC_22820867","title":"Acute 5-HT₁A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions.","date":"2012","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22820867","citation_count":59,"is_preprint":false},{"pmid":"1973941","id":"PMC_1973941","title":"Neurochemistry and neurophysiology of buspirone and gepirone: interactions at presynaptic and postsynaptic 5-HT1A receptors.","date":"1990","source":"Journal of clinical psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1973941","citation_count":58,"is_preprint":false},{"pmid":"15939084","id":"PMC_15939084","title":"Ontogeny of 5-HT1A receptor expression in the developing hippocampus.","date":"2005","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/15939084","citation_count":56,"is_preprint":false},{"pmid":"18685031","id":"PMC_18685031","title":"Targeting of the 5-HT1A serotonin receptor to neuronal dendrites is mediated by Yif1B.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18685031","citation_count":56,"is_preprint":false},{"pmid":"1828347","id":"PMC_1828347","title":"Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.","date":"1991","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1828347","citation_count":54,"is_preprint":false},{"pmid":"10396127","id":"PMC_10396127","title":"The 5-HT1A receptor and its ligands: structure and function.","date":"1999","source":"Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques","url":"https://pubmed.ncbi.nlm.nih.gov/10396127","citation_count":53,"is_preprint":false},{"pmid":"9292630","id":"PMC_9292630","title":"Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity.","date":"1997","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9292630","citation_count":52,"is_preprint":false},{"pmid":"10617139","id":"PMC_10617139","title":"Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors.","date":"2000","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10617139","citation_count":51,"is_preprint":false},{"pmid":"9022796","id":"PMC_9022796","title":"5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.","date":"1997","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9022796","citation_count":50,"is_preprint":false},{"pmid":"9806333","id":"PMC_9806333","title":"Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.","date":"1998","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9806333","citation_count":49,"is_preprint":false},{"pmid":"16025319","id":"PMC_16025319","title":"The 5-HT1A receptor and the stimulus effects of LSD in the rat.","date":"2005","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16025319","citation_count":47,"is_preprint":false},{"pmid":"27897266","id":"PMC_27897266","title":"Evaluation of association of common variants in HTR1A and HTR5A with schizophrenia and executive function.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27897266","citation_count":47,"is_preprint":false},{"pmid":"8855520","id":"PMC_8855520","title":"New 5-HT1A receptor antagonist: [3H]p-MPPF.","date":"1996","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8855520","citation_count":47,"is_preprint":false},{"pmid":"10073487","id":"PMC_10073487","title":"Androgens and estrogens modulate 5-HT1A and 5-HT1B agonist effects on aggression.","date":"1999","source":"Physiology & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/10073487","citation_count":47,"is_preprint":false},{"pmid":"8466538","id":"PMC_8466538","title":"Prenatal developmental expression of rat brain 5-HT1A receptor gene followed by PCR.","date":"1993","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8466538","citation_count":45,"is_preprint":false},{"pmid":"25913021","id":"PMC_25913021","title":"5-HT1A Receptor-Mediated Autoinhibition and the Control of Serotonergic Cell Firing.","date":"2015","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25913021","citation_count":44,"is_preprint":false},{"pmid":"30807072","id":"PMC_30807072","title":"Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm.","date":"2019","source":"Journal of psychiatry & neuroscience : JPN","url":"https://pubmed.ncbi.nlm.nih.gov/30807072","citation_count":44,"is_preprint":false},{"pmid":"14985704","id":"PMC_14985704","title":"Occupancy of agonist drugs at the 5-HT1A receptor.","date":"2004","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/14985704","citation_count":44,"is_preprint":false},{"pmid":"21036859","id":"PMC_21036859","title":"Brainstem changes in 5-HT1A receptor availability during migraine attack.","date":"2010","source":"Cephalalgia : an international journal of headache","url":"https://pubmed.ncbi.nlm.nih.gov/21036859","citation_count":44,"is_preprint":false},{"pmid":"26324408","id":"PMC_26324408","title":"5-HT1A Autoreceptors in the Dorsal Raphe Nucleus Convey Vulnerability to Compulsive Cocaine Seeking.","date":"2015","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26324408","citation_count":41,"is_preprint":false},{"pmid":"23516322","id":"PMC_23516322","title":"The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy.","date":"2013","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23516322","citation_count":40,"is_preprint":false},{"pmid":"1702490","id":"PMC_1702490","title":"Influence of 5-HT1A receptor agonists on sympathetic and parasympathetic nerve activity.","date":"1990","source":"Journal of cardiovascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1702490","citation_count":39,"is_preprint":false},{"pmid":"20638825","id":"PMC_20638825","title":"The HTR1A and HTR1B receptor genes influence stress-related information processing.","date":"2010","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20638825","citation_count":38,"is_preprint":false},{"pmid":"29275155","id":"PMC_29275155","title":"HTR1A/1B DNA methylation may predict escitalopram treatment response in depressed Chinese Han patients.","date":"2017","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/29275155","citation_count":38,"is_preprint":false},{"pmid":"15778876","id":"PMC_15778876","title":"5-HT1A receptor expression during memory formation.","date":"2005","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15778876","citation_count":38,"is_preprint":false},{"pmid":"14654304","id":"PMC_14654304","title":"Opioid hyperalgesia and tolerance versus 5-HT1A receptor-mediated inverse tolerance.","date":"2003","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/14654304","citation_count":37,"is_preprint":false},{"pmid":"15777775","id":"PMC_15777775","title":"Role of 5-HT1A and 5-HT1B receptors in the antinociceptive effect of tramadol.","date":"2005","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15777775","citation_count":36,"is_preprint":false},{"pmid":"21750580","id":"PMC_21750580","title":"Presynaptic 5-HT1A is related to 5-HTT receptor density in the human brain.","date":"2011","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21750580","citation_count":36,"is_preprint":false},{"pmid":"8788494","id":"PMC_8788494","title":"Development of 5-HT1A receptor antagonists.","date":"1996","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/8788494","citation_count":36,"is_preprint":false},{"pmid":"19447286","id":"PMC_19447286","title":"Memory time-course: mRNA 5-HT1A and 5-HT7 receptors.","date":"2009","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/19447286","citation_count":36,"is_preprint":false},{"pmid":"18715570","id":"PMC_18715570","title":"Serotonin receptor HTR1A and HTR2C variants and personality traits in suicide attempters and controls.","date":"2008","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/18715570","citation_count":35,"is_preprint":false},{"pmid":"31765686","id":"PMC_31765686","title":"Dopaminergic neuroprotective effects of rotigotine via 5-HT1A receptors: Possibly involvement of metallothionein expression in astrocytes.","date":"2019","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/31765686","citation_count":34,"is_preprint":false},{"pmid":"18163385","id":"PMC_18163385","title":"Association study between the serotonin 1A receptor (HTR1A) gene and neuroticism, major depression, and anxiety disorders.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18163385","citation_count":34,"is_preprint":false},{"pmid":"25514753","id":"PMC_25514753","title":"The functional -1019C/G HTR1A polymorphism and mechanisms of fear.","date":"2014","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25514753","citation_count":33,"is_preprint":false},{"pmid":"2569265","id":"PMC_2569265","title":"Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.","date":"1989","source":"The American journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/2569265","citation_count":33,"is_preprint":false},{"pmid":"22788968","id":"PMC_22788968","title":"The therapeutic potential of 5-HT1A receptors: a patent review.","date":"2012","source":"Expert opinion on therapeutic patents","url":"https://pubmed.ncbi.nlm.nih.gov/22788968","citation_count":31,"is_preprint":false},{"pmid":"21051107","id":"PMC_21051107","title":"Regulation of cortical and striatal 5-HT1A receptors in the MPTP-lesioned macaque.","date":"2010","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/21051107","citation_count":31,"is_preprint":false},{"pmid":"20817074","id":"PMC_20817074","title":"Panic disorder and serotonergic genes (SLC6A4, HTR1A and HTR2A): Association and interaction with childhood trauma and parenting.","date":"2010","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/20817074","citation_count":30,"is_preprint":false},{"pmid":"26441141","id":"PMC_26441141","title":"TREK1 channel blockade induces an antidepressant-like response synergizing with 5-HT1A receptor signaling.","date":"2015","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26441141","citation_count":30,"is_preprint":false},{"pmid":"12922937","id":"PMC_12922937","title":"Effect of fentanyl on 5-HT efflux involves both opioid and 5-HT1A receptors.","date":"2003","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12922937","citation_count":30,"is_preprint":false},{"pmid":"1816558","id":"PMC_1816558","title":"Structure-activity relationships at 5-HT1A receptors: binding profiles and intrinsic activity.","date":"1991","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/1816558","citation_count":29,"is_preprint":false},{"pmid":"34458005","id":"PMC_34458005","title":"The epigenetic role of HTR1A antagonist in facilitaing GnRH expression for pubertal initiation control.","date":"2021","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/34458005","citation_count":29,"is_preprint":false},{"pmid":"10821446","id":"PMC_10821446","title":"Modulation of 5-HT1A receptor mediated response by fluoxetine in rat brain.","date":"2000","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/10821446","citation_count":28,"is_preprint":false},{"pmid":"18499474","id":"PMC_18499474","title":"HES1 regulates 5-HT1A receptor gene transcription at a functional polymorphism: essential role in developmental expression.","date":"2008","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/18499474","citation_count":28,"is_preprint":false},{"pmid":"2052135","id":"PMC_2052135","title":"The 5-HT1A receptor: an overview of recent advances.","date":"1991","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/2052135","citation_count":27,"is_preprint":false},{"pmid":"7909594","id":"PMC_7909594","title":"Anxiolytic and antidepressant mechanisms of 5-HT1A drugs in the pigeon: contributions from behavioral studies.","date":"1994","source":"Neuroscience and biobehavioral reviews","url":"https://pubmed.ncbi.nlm.nih.gov/7909594","citation_count":26,"is_preprint":false},{"pmid":"24258351","id":"PMC_24258351","title":"Activation of postsynaptic 5-HT1A receptors improve stress adaptation.","date":"2013","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24258351","citation_count":26,"is_preprint":false},{"pmid":"30124346","id":"PMC_30124346","title":"5-HT1A receptor ligands and their therapeutic applications: review of new patents.","date":"2018","source":"Expert opinion on therapeutic patents","url":"https://pubmed.ncbi.nlm.nih.gov/30124346","citation_count":25,"is_preprint":false},{"pmid":"24946016","id":"PMC_24946016","title":"Stress-induced alterations in 5-HT1A receptor transcriptional modulators NUDR and Freud-1.","date":"2014","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24946016","citation_count":25,"is_preprint":false},{"pmid":"35199941","id":"PMC_35199941","title":"HTR1A Inhibits the Progression of Triple-Negative Breast Cancer via TGF-β Canonical and Noncanonical Pathways.","date":"2022","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/35199941","citation_count":24,"is_preprint":false},{"pmid":"18853255","id":"PMC_18853255","title":"Specific oligomerization of the 5-HT1A receptor in the plasma membrane.","date":"2008","source":"Glycoconjugate journal","url":"https://pubmed.ncbi.nlm.nih.gov/18853255","citation_count":24,"is_preprint":false},{"pmid":"30618734","id":"PMC_30618734","title":"5-HT1A Receptor Function Makes Wound Healing a Happier Process.","date":"2018","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30618734","citation_count":23,"is_preprint":false},{"pmid":"23992341","id":"PMC_23992341","title":"PET radiotracers for molecular imaging of serotonin 5-HT1A receptors.","date":"2014","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23992341","citation_count":23,"is_preprint":false},{"pmid":"16147954","id":"PMC_16147954","title":"Treatment of cerebellar ataxia with 5-HT1A agonist.","date":"2005","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16147954","citation_count":23,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50911,"output_tokens":6228,"usd":0.123077,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14999,"output_tokens":6317,"usd":0.11646,"stage2_stop_reason":"end_turn"},"total_usd":0.239537,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"The 5-HT1A receptor couples to inhibitory G proteins (Gi/o) to inhibit adenylyl cyclase; transfection of the cloned receptor cDNA into naive cells revealed multiple signal transduction pathways including novel signaling linkages and elucidated mechanisms of receptor desensitization.\",\n      \"method\": \"Recombinant receptor expression in heterologous cell lines, cAMP/adenylyl cyclase assays, site-directed mutagenesis\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution in heterologous cells, functional assays, mutagenesis, replicated across many labs over a decade\",\n      \"pmids\": [\"10482904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"DMT acts as a full agonist at 5-HT1A receptors, inhibiting forskolin-stimulated adenylate cyclase activity in rat hippocampus with EC50 ~4 µM; GTP sensitivity of radioligand binding confirmed agonist activity.\",\n      \"method\": \"Radioligand binding with GTP shift, adenylate cyclase assay in rat hippocampal membranes\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro functional assay with biochemical readout, single study\",\n      \"pmids\": [\"1828347\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Methiothepin and spiperone act as inverse agonists at the 5-HT1A receptor, inhibiting both agonist-stimulated and basal [35S]GTPγS binding in CHO cells expressing the receptor; spiperone stabilizes receptor forms uncoupled from G proteins, while methiothepin stabilizes an inactive receptor form that retains G protein coupling.\",\n      \"method\": \"[35S]GTPγS binding assay in CHO-5-HT1A cells, extended ternary complex model simulation, modulation by GDP and sodium ion concentration\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted receptor in defined cell system, multiple pharmacological conditions, mechanistic modeling\",\n      \"pmids\": [\"10617139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"5-HT1A receptors mediate hyperpolarization of orexin/hypocretin neurons via activation of G protein-coupled inward rectifier potassium (GIRK) channels (single-channel conductance ~33.8 pS); 5-HT1A receptor-like immunoreactivity was detected on orexin neurons and serotonergic nerve endings apposed to orexin neurons.\",\n      \"method\": \"Patch-clamp electrophysiology (whole-cell and single-channel) in hypothalamic slices from orexin-EGFP transgenic mice, pharmacological blockade with WAY100635, Ba2+ channel blockade, immunohistochemistry\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct electrophysiology with selective pharmacology, single-channel conductance measurement, and immunohistochemical localization in the same study\",\n      \"pmids\": [\"15306649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The intracellular trafficking protein Yif1B interacts with the C-terminal domain of the 5-HT1A receptor and is required for targeting of the receptor to distal dendrites; siRNA knockdown of Yif1B specifically prevented dendritic addressing of 5-HT1A receptor without affecting other receptors (sst2A, P2X2, 5-HT3A).\",\n      \"method\": \"Yeast two-hybrid screen using 5-HT1A C-terminal 17 aa as bait, GST pull-down with rat brain extracts and transfected cell lines, co-localization imaging, siRNA knockdown in primary neuron cultures\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — yeast two-hybrid, GST pull-down, reciprocal co-localization, and functional siRNA knockdown with specific dendritic targeting readout in one study\",\n      \"pmids\": [\"18685031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"5-HT1A receptor immunoreactivity is localized to the somatodendritic compartment (dendritic shaft, branches, spines, perikaryon) of raphe neurons and to the axon hillock of cortical and hippocampal pyramidal neurons; astrocytes and other non-neuronal cells also express the receptor.\",\n      \"method\": \"Immunocytochemistry with antipeptide antibody (aa170-186) in perfusion-fixed primate brain (Macaca fascicularis)\",\n      \"journal\": \"Neuropsychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct immunocytochemical localization in primate brain, validated antibody, multiple cell types characterized\",\n      \"pmids\": [\"8719028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"5-HT1A receptor is palmitoylated in human and rodent brains; ZDHHC21 is the major palmitoyl acyltransferase responsible; depletion of ZDHHC21 reduces palmitoylation and signaling functions of 5-HT1AR; miR-30e negatively regulates ZDHHC21 expression; reduced 5-HT1AR palmitoylation and ZDHHC21 expression were found in post-mortem prefrontal cortex of MDD suicides.\",\n      \"method\": \"Palmitoylation assays in brain tissue and cell lines, siRNA knockdown of ZDHHC21, palmitoylation-deficient mutant, microRNA analysis, post-mortem human brain analysis, behavioral assays in mice with forebrain-specific ZDHHC21 knockdown\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal biochemical methods (palmitoylation assay, mutagenesis, KD), in vivo behavioral validation, human post-mortem replication in single study\",\n      \"pmids\": [\"31477731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"5-HT1A receptors form specific homo-oligomers at the plasma membrane of living cells, as demonstrated by FRET between CFP- and YFP-tagged receptors; palmitoylation promotes receptor localization to lipid-rich microdomains and increases effective surface density, thereby facilitating oligomerization — a palmitoylation-deficient mutant showed reduced FRET efficiency.\",\n      \"method\": \"2-excitation FRET with spectral microscopy in living cells, CFP/YFP-tagged 5-HT1A receptors, palmitoylation-deficient mutant analysis\",\n      \"journal\": \"Glycoconjugate journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live-cell FRET with quantitative analysis and mutagenesis, single lab\",\n      \"pmids\": [\"18853255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"5-HT1A and 5-HT7 receptors form homo- and heterodimers both in vitro and in vivo; heterodimerization plays a role in regulation of receptor-mediated signaling and internalization.\",\n      \"method\": \"Co-immunoprecipitation and FRET-based dimerization assays in vitro and in vivo (as described in cited review citing primary data)\",\n      \"journal\": \"CNS neuroscience & therapeutics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — described in a review citing primary work; abstract does not detail the specific experimental methods used to establish dimerization\",\n      \"pmids\": [\"24935787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"5-HT2A receptor activation in the hypothalamic paraventricular nucleus (PVN) induces heterologous desensitization of 5-HT1A receptors within individual neuroendocrine cells; 5-HT1A and 5-HT2A receptors are colocalized in oxytocin and CRF neurons of the PVN; microinjection of 5-HT2A antagonist MDL100,907 prevented desensitization.\",\n      \"method\": \"In vivo neuroendocrine functional assay (oxytocin and ACTH responses to 8-OH-DPAT), microinjection of 5-HT2A antagonist into PVN, double-label immunocytochemistry\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo pharmacological epistasis combined with anatomical colocalization, single lab\",\n      \"pmids\": [\"15064330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Mice engineered with higher 5-HT1A autoreceptor levels in raphe nuclei (1A-High) show robustly increased raphe firing rate inhibition, increased behavioral despair, and no behavioral response to antidepressants, establishing a causal relationship between 5-HT1A autoreceptor level, raphe firing, stress resilience, and antidepressant response.\",\n      \"method\": \"Genetic mouse models selectively manipulating raphe 5-HT1A autoreceptors; electrophysiological recording of raphe firing; in vivo microdialysis; behavioral testing; antidepressant response assays\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — selective genetic manipulation in vivo, electrophysiology, microdialysis, behavioral readouts, and rescue experiment in single rigorous study\",\n      \"pmids\": [\"20152112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Acute siRNA-mediated knockdown of 5-HT1A autoreceptors in the dorsal raphe nucleus reduces receptor mRNA and binding, abolishes 8-OH-DPAT-induced hypothermia, and increases prefrontal 5-HT release during stress, producing antidepressant-like effects and augmenting fluoxetine-evoked 5-HT release.\",\n      \"method\": \"Stereotaxic intra-DRN siRNA infusion, in situ hybridization, receptor binding, in vivo microdialysis, behavioral tests (tail suspension, forced swim), 8-OH-DPAT-induced hypothermia\",\n      \"journal\": \"Psychopharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (molecular, neurochemical, behavioral) in single study with appropriate controls including 5-HT1A KO mice\",\n      \"pmids\": [\"22820867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Adrenal corticosteroids selectively regulate hippocampal 5-HT1A receptor expression; adrenalectomy increases 5-HT1A receptor mRNA and binding throughout the hippocampus, and exogenous corticosterone replacement restores levels to sham values.\",\n      \"method\": \"In situ hybridization for 5-HT1A mRNA, in vitro receptor autoradiography with [3H]8-OH-DPAT, adrenalectomy and corticosterone replacement in rats\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — parallel mRNA and binding measurements with bidirectional pharmacological manipulation (ADX + CORT rescue), multiple hippocampal subfields, two time-points\",\n      \"pmids\": [\"8441016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The C(-1019)G (rs6295) polymorphism in the HTR1A promoter selectively blocks repression by the transcription factors NUDR/Deaf-1, Hes1, and Hes5 at the autoreceptor locus, resulting in increased 5-HT1A autoreceptor expression in raphe neurons.\",\n      \"method\": \"Promoter-reporter assays in neuronal cell lines, transcription factor binding studies, in vitro and in vivo allele-specific repression assays\",\n      \"journal\": \"The Neuroscientist\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell culture reporter assays and transcription factor binding established mechanism; described in a review but citing multiple primary experiments from same group\",\n      \"pmids\": [\"15534042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HES1 strongly represses 5-HT1A receptor transcription via a consensus HES site in the promoter, including at the G(-1019) allele (unlike HES5); HES6 reverses HES1- and HES5-mediated repression; HES1 knockout mice show elevated 5-HT1A receptor RNA and protein in hindbrain and midbrain at E12.5, establishing HES1 as required for correct developmental expression.\",\n      \"method\": \"Promoter-reporter assays in neuronal and non-neuronal cells, site-directed mutagenesis of HES consensus site, HES1−/− mouse embryos analyzed by in situ hybridization and immunohistochemistry\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis of functional element, genetic KO validation in vivo, multiple cell types, two orthogonal readouts (mRNA and protein)\",\n      \"pmids\": [\"18499474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"BDNF deficiency (heterozygous BDNF +/− mice) attenuates 5-HT1A receptor-stimulated [35S]GTPγS binding in the median and dorsal raphe nucleus and hippocampus without changing receptor number, indicating that BDNF regulates 5-HT1A receptor–G protein coupling efficiency.\",\n      \"method\": \"Agonist-stimulated [35S]GTPγS binding autoradiography, radioligand binding for receptor number, two-bottle choice ethanol intake in BDNF +/− vs WT mice\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional G-protein coupling assay dissociating from receptor number, genetic model, multiple brain regions\",\n      \"pmids\": [\"12753073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HTR1A antagonism (WAY-100635) in GT1-7 GnRH neuronal cells upregulates GnRH expression by reducing CBX4 (a PRC1 component) expression, decreasing H2AK119 ubiquitination at the GnRH promoter, and degrading the PRC1 complex; this is mediated through suppression of PI3K/Akt and MAPK/ERK pathways.\",\n      \"method\": \"RNA-seq, ChIP-seq for CBX4 and H2AK119ub, co-immunoprecipitation (RING2, YY1, CBX4 interaction), pharmacological treatment of GT1-7 cells with WAY-100635\",\n      \"journal\": \"Molecular therapy. Nucleic acids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq and Co-IP in defined cell line, multiple orthogonal molecular methods, single lab\",\n      \"pmids\": [\"34458005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HTR1A interacts with TRIM21 and PSMD7 to inhibit ubiquitin-proteasome-dependent degradation of TGF-β receptor II (TβRII), thereby suppressing both canonical and noncanonical TGF-β signaling pathways in triple-negative breast cancer cells.\",\n      \"method\": \"Co-immunoprecipitation assays, RNA-seq, siRNA knockdown, in vivo and in vitro functional experiments in breast cancer models\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifying interacting partners, RNA-seq, functional KD, single lab\",\n      \"pmids\": [\"35199941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"5-HT1A receptor agonists inhibit the firing rate of 5-HT-containing dorsal raphe neurons and inhibit cortical/hippocampal 5-HT synthesis via presynaptic somatodendritic autoreceptors; postsynaptic 5-HT1A receptors are negatively coupled to adenylyl cyclase.\",\n      \"method\": \"Electrophysiology (in vitro and in vivo raphe neuron firing), neurochemical assays of 5-HT synthesis inhibition, adenylyl cyclase functional assays\",\n      \"journal\": \"Journal of clinical psychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional readouts (electrophysiology + neurochemistry), replicated across labs in same era\",\n      \"pmids\": [\"1973941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"5-HT1A receptor coupled primarily to Gi3 in 5-HT neurons and to Gi2 in hippocampal neurons; Gβγ subunit-mediated signaling opens potassium channels and closes calcium channels to reduce neuronal activity; in hippocampal neurons (but not 5-HT neurons), 5-HT1A receptor signals to activate ERK1/2 and can also engage ACII, PLC/PKC, CaMKII, and PI3K/Akt pathways through Gβγ and tyrosine kinase receptor crosstalk.\",\n      \"method\": \"G protein coupling studies in neuronal cell lines and primary neurons, signaling pathway assays (ERK, PI3K/Akt, CAMKII), ion channel recordings; review compiling primary experimental data\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — review synthesizing multiple primary experiments from several labs; individual pathway findings are tier 1–2 but assessed collectively from a review abstract\",\n      \"pmids\": [\"31079617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"5-HT1A autoreceptors in the dorsal raphe nucleus are necessary for cocaine conditioned place preference; inhibition of dorsal raphe 5-HT1A autoreceptors attenuates compulsive cocaine self-administration in rats with extended (6 h) but not limited (1 h) access.\",\n      \"method\": \"5-HT neuron-specific 5-HT1A autoreceptor gene knockdown (conditional KO), DREADD-mediated stimulation of DRN→NAc serotonergic projections, rat cocaine self-administration model\",\n      \"journal\": \"Neuropsychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific genetic manipulation and chemogenetics with defined behavioral readouts, single lab\",\n      \"pmids\": [\"26324408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"5-HT1A receptor protein expression in the developing rat hippocampus begins at initial stages of embryonic development, is concentrated around cell bodies before distributing to dendrites as neurons mature, and is transiently expressed in S100/GFAP-positive glia during early postnatal development.\",\n      \"method\": \"Immunohistochemistry with validated anti-5-HT1A antibody in developing rat hippocampus from embryonic to early postnatal stages\",\n      \"journal\": \"Brain research. Developmental brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct immunohistochemical localization with developmental time course, validated antibody, multiple cell types\",\n      \"pmids\": [\"15939084\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Rotigotine stimulates astrocyte 5-HT1A receptors to increase astrocyte proliferation and upregulate metallothionein (MT)-1,2 expression; conditioned medium from rotigotine-treated astrocytes protects dopaminergic neurons from 6-OHDA toxicity; these effects were completely blocked by a 5-HT1A antagonist or MT-1,2 antibody in vitro and in vivo.\",\n      \"method\": \"Primary astrocyte cultures, conditioned medium experiments, 5-HT1A antagonist blockade, MT-1,2 antibody neutralization, subcutaneous rotigotine in 6-OHDA mouse model with immunohistochemistry\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo pharmacological blockade with defined molecular readout (MT expression), single lab\",\n      \"pmids\": [\"31765686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Stimulation of postsynaptic (not presynaptic) 5-HT1A receptors impairs passive avoidance retention in rats; the memory deficit is blocked by selective 5-HT1A antagonists but not 5-HT2A/2C antagonists or beta-blockers; 5-HT1A receptor stimulation interferes with both acquisition and retrieval phases of learning.\",\n      \"method\": \"Step-through passive avoidance test in rats, selective pharmacological agonists and antagonists (WAY 100135, ketanserin, alprenolol), state-dependent learning paradigm, tryptophan depletion (PCPA)\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple pharmacological dissections with receptor-selective tools and behavioral readouts, single lab\",\n      \"pmids\": [\"9806333\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HTR1A (5-HT1A) is a Gi/o-coupled GPCR that functions as both a somatodendritic autoreceptor on raphe 5-HT neurons — where Gi3-mediated inhibition of adenylyl cyclase and Gβγ-dependent opening of GIRK channels suppress neuronal firing — and as a postsynaptic heteroreceptor in limbic and cortical regions, where Gi2 coupling additionally activates ERK1/2, PI3K/Akt, and CaMKII pathways; its dendritic targeting requires interaction with the trafficking protein Yif1B; its activity is modulated by ZDHHC21-mediated palmitoylation, by corticosteroid-regulated transcription, and by transcription factors HES1/HES5/Deaf-1 acting at the functional C(-1019)G promoter polymorphism to differentially regulate autoreceptor versus heteroreceptor expression levels, with autoreceptor-level control causally determining raphe firing rate, stress resilience, and antidepressant response.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HTR1A (5-HT1A) is a Gi/o-coupled serotonin receptor that suppresses neuronal activity, serving both as a somatodendritic autoreceptor on raphe serotonergic neurons and as a postsynaptic heteroreceptor in cortical, hippocampal, and hypothalamic circuits [#0, #18]. The receptor couples to inhibitory G proteins to inhibit adenylyl cyclase, and its activation hyperpolarizes neurons by opening G protein-coupled inwardly rectifying potassium (GIRK) channels [#3], reducing the firing of dorsal raphe 5-HT neurons and limiting forebrain 5-HT synthesis [#18]. Coupling is region-selective \\u2014 Gi3 in 5-HT neurons versus Gi2 in hippocampal neurons \\u2014 with G\\u03b2\\u03b3-driven ion channel modulation reducing excitability and, in hippocampal neurons, additional engagement of ERK1/2 and PI3K/Akt signaling [#19]. Receptor pharmacology spans full agonism, inverse agonism that stabilizes G-protein-uncoupled or inactive states, and ligand-dependent control of the ternary complex [#1, #2]. Spatial deployment of the receptor is actively controlled: the C-terminus binds the trafficking protein Yif1B, which is required for dendritic targeting [#4], while ZDHHC21-mediated palmitoylation supports signaling competence and partitioning into lipid microdomains that promote receptor homo-oligomerization [#6, #7]. Expression is set transcriptionally by Deaf-1/HES1/HES5 repressors acting at the promoter, where the C(-1019)G polymorphism relieves autoreceptor repression and elevates raphe receptor levels [#13, #14], and by corticosteroid regulation of hippocampal expression [#12]. Autoreceptor abundance is causally determinative: genetically elevated raphe autoreceptor levels increase firing inhibition, behavioral despair, and antidepressant resistance, whereas autoreceptor knockdown elevates prefrontal 5-HT release and produces antidepressant-like effects [#10, #11]. Beyond neuronal signaling, HTR1A also acts in non-neuronal contexts, stabilizing TGF-\\u03b2 receptor II against proteasomal degradation in breast cancer cells [#17] and, in serotonergic and GnRH cell models, regulating gene expression through PI3K/Akt and MAPK/ERK pathways [#16].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Established the core physiological dichotomy: 5-HT1A acts as a somatodendritic autoreceptor inhibiting raphe firing and 5-HT synthesis, and as a postsynaptic receptor negatively coupled to adenylyl cyclase, defining the receptor's two-compartment role.\",\n      \"evidence\": \"Electrophysiology of raphe neuron firing, neurochemical 5-HT synthesis assays, and adenylyl cyclase assays\",\n      \"pmids\": [\"1973941\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not resolve which Gi/o isoforms mediate each compartment\", \"Mechanism of receptor desensitization not addressed\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Demonstrated functional agonist coupling by showing a ligand inhibits forskolin-stimulated adenylate cyclase with GTP-sensitive binding, confirming the Gi-linked cyclase-inhibitory readout in native tissue.\",\n      \"evidence\": \"Radioligand binding with GTP shift and adenylate cyclase assay in rat hippocampal membranes\",\n      \"pmids\": [\"1828347\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single agonist tested in one tissue\", \"No downstream pathway beyond cAMP examined\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Revealed that receptor expression is not static but set by endocrine state, with corticosteroids bidirectionally regulating hippocampal 5-HT1A mRNA and binding.\",\n      \"evidence\": \"In situ hybridization and receptor autoradiography with adrenalectomy and corticosterone replacement in rats\",\n      \"pmids\": [\"8441016\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcription factors mediating corticosteroid effect not identified\", \"Effect on raphe autoreceptors versus heteroreceptors not distinguished\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Mapped the subcellular distribution underlying the autoreceptor/heteroreceptor distinction, placing the receptor in the somatodendritic compartment of raphe neurons and the axon hillock of pyramidal neurons.\",\n      \"evidence\": \"Immunocytochemistry with antipeptide antibody in primate brain\",\n      \"pmids\": [\"8719028\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trafficking mechanism producing compartment-specific localization unknown\", \"Functional consequence of astrocytic expression unaddressed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Reconstituted the cloned receptor in heterologous cells to define Gi/o coupling, multiple downstream signaling linkages, and desensitization mechanisms independent of neuronal context.\",\n      \"evidence\": \"Recombinant expression in cell lines, cAMP assays, site-directed mutagenesis\",\n      \"pmids\": [\"10482904\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map G-protein isoform specificity by neuron type\", \"Endogenous neuronal partners not captured in heterologous system\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Distinguished classes of antagonist behavior at the receptor, showing inverse agonists suppress basal G-protein activity and stabilize distinct receptor conformations within the ternary complex.\",\n      \"evidence\": \"[35S]GTP\\u03b3S binding in CHO-5-HT1A cells with ternary complex modeling and ion modulation\",\n      \"pmids\": [\"10617139\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the stabilized conformations not resolved\", \"In vivo relevance of constitutive activity untested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed that receptor signaling efficiency is regulated by a neurotrophin, as BDNF deficiency reduces 5-HT1A\\u2013G protein coupling without altering receptor number.\",\n      \"evidence\": \"Agonist-stimulated [35S]GTP\\u03b3S binding autoradiography and radioligand binding in BDNF +/\\u2212 mice\",\n      \"pmids\": [\"12753073\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular link between BDNF signaling and coupling efficiency unidentified\", \"Behavioral consequence of altered coupling not isolated\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Resolved the ion-channel effector for inhibition, demonstrating 5-HT1A hyperpolarizes target neurons by activating GIRK channels with defined single-channel conductance.\",\n      \"evidence\": \"Patch-clamp electrophysiology in orexin neurons with selective pharmacology and immunohistochemistry\",\n      \"pmids\": [\"15306649\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"G\\u03b2\\u03b3 versus G\\u03b1 contribution to channel gating not dissected here\", \"Limited to one neuronal population\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrated cross-receptor regulation, with 5-HT2A activation causing heterologous desensitization of co-localized 5-HT1A receptors within single neuroendocrine cells.\",\n      \"evidence\": \"In vivo neuroendocrine assays with intra-PVN 5-HT2A antagonist microinjection and double-label immunocytochemistry\",\n      \"pmids\": [\"15064330\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Intracellular signaling mediating cross-desensitization unidentified\", \"Restricted to PVN neuroendocrine cells\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified the transcriptional basis of the disease-associated promoter variant, showing C(-1019)G blocks Deaf-1/Hes repression to raise autoreceptor expression.\",\n      \"evidence\": \"Promoter-reporter assays and transcription factor binding studies in neuronal cell lines\",\n      \"pmids\": [\"15534042\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Allele-specific effects on heteroreceptors versus autoreceptors not fully separated\", \"In vivo human consequences inferred\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Characterized the developmental trajectory of receptor expression, from perinuclear localization in immature neurons to dendritic distribution with maturation, plus transient glial expression.\",\n      \"evidence\": \"Immunohistochemistry across embryonic to postnatal rat hippocampus\",\n      \"pmids\": [\"15939084\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism driving the perinuclear-to-dendritic shift not defined\", \"Function of transient glial expression unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified Yif1B as the C-terminal-binding trafficking partner required specifically for dendritic targeting, providing a molecular basis for compartment-specific receptor delivery.\",\n      \"evidence\": \"Yeast two-hybrid, GST pull-down, co-localization, and siRNA knockdown in primary neurons\",\n      \"pmids\": [\"18685031\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Yif1B selects 5-HT1A over other cargo unresolved\", \"Role in raphe autoreceptor targeting not directly tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Showed the receptor self-associates into plasma-membrane homo-oligomers and that palmitoylation promotes oligomerization via lipid-microdomain partitioning.\",\n      \"evidence\": \"Live-cell 2-excitation FRET with CFP/YFP-tagged receptors and palmitoylation-deficient mutant\",\n      \"pmids\": [\"18853255\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of oligomerization for signaling not established\", \"Single-lab live-cell FRET\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Established HES1 as a developmental repressor of receptor transcription required in vivo, acting at a promoter consensus site including the G(-1019) allele, with HES6 relieving repression.\",\n      \"evidence\": \"Promoter-reporter assays, mutagenesis of HES site, and HES1\\u2212/\\u2212 mouse embryo analysis\",\n      \"pmids\": [\"18499474\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Adult versus developmental contributions of HES1 not separated\", \"Interplay with corticosteroid regulation untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Established causality between autoreceptor level and behavior, with genetically elevated raphe autoreceptors increasing firing inhibition, despair, and antidepressant resistance.\",\n      \"evidence\": \"Genetic mouse models with selective raphe autoreceptor manipulation, electrophysiology, microdialysis, and behavior\",\n      \"pmids\": [\"20152112\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not test acute, reversible manipulation\", \"Heteroreceptor contribution held separate but not co-varied\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Confirmed the autoreceptor as a therapeutic lever, showing acute DRN autoreceptor knockdown increases prefrontal 5-HT release and produces antidepressant-like effects that augment fluoxetine.\",\n      \"evidence\": \"Intra-DRN siRNA, in situ hybridization, microdialysis, and behavioral tests with 5-HT1A KO controls\",\n      \"pmids\": [\"22820867\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Durability of knockdown effect not assessed\", \"Effect on heteroreceptor-mediated responses not measured\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Extended autoreceptor function to addiction circuitry, showing DRN 5-HT1A autoreceptors are necessary for cocaine place preference and compulsive self-administration under extended access.\",\n      \"evidence\": \"5-HT-neuron-specific conditional knockdown, DREADD stimulation of DRN\\u2192NAc projections, rat self-administration\",\n      \"pmids\": [\"26324408\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream NAc circuit mechanism not resolved\", \"Single-lab behavioral model\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved region-specific G-protein coupling (Gi3 in 5-HT neurons, Gi2 in hippocampal neurons) and the downstream divergence into ion-channel inhibition versus ERK/PI3K-Akt/CaMKII signaling.\",\n      \"evidence\": \"Compiled G-protein coupling, signaling pathway assays, and ion channel recordings across neuronal systems\",\n      \"pmids\": [\"31079617\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Determinants of isoform-selective coupling unknown\", \"Synthesized from multiple primary sources\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified ZDHHC21 as the palmitoyl acyltransferase controlling receptor signaling competence, linked reduced palmitoylation to MDD pathology and to miR-30e regulation.\",\n      \"evidence\": \"Palmitoylation assays, ZDHHC21 knockdown, palmitoylation-deficient mutant, post-mortem human cortex, and behavior in forebrain ZDHHC21-knockdown mice\",\n      \"pmids\": [\"31477731\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal direction of palmitoylation changes in human MDD not established\", \"Effect on autoreceptor versus heteroreceptor pools not separated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined a neuroprotective astrocytic function, with astrocyte 5-HT1A stimulation driving metallothionein upregulation and dopaminergic neuroprotection.\",\n      \"evidence\": \"Primary astrocyte cultures, conditioned-medium and antibody-neutralization experiments, and 6-OHDA mouse model\",\n      \"pmids\": [\"31765686\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signaling pathway from astrocyte 5-HT1A to MT induction not mapped\", \"Single-lab pharmacological model\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed receptor signaling controls epigenetic gene regulation, as HTR1A antagonism upregulates GnRH by destabilizing PRC1/CBX4 and reducing H2AK119 ubiquitination through PI3K/Akt and MAPK/ERK suppression.\",\n      \"evidence\": \"RNA-seq, ChIP-seq, and Co-IP with WAY-100635 treatment in GT1-7 GnRH neuronal cells\",\n      \"pmids\": [\"34458005\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of GnRH regulation untested\", \"Single cell line\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Uncovered a non-canonical, signaling-independent scaffolding role, with HTR1A binding TRIM21 and PSMD7 to protect TGF-\\u03b2 receptor II from proteasomal degradation in breast cancer.\",\n      \"evidence\": \"Co-IP, RNA-seq, siRNA knockdown, and in vivo/in vitro breast cancer functional assays\",\n      \"pmids\": [\"35199941\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether G-protein signaling contributes to this role unknown\", \"Single-lab cancer model\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How transcriptional control, palmitoylation, trafficking, and oligomerization are integrated to set the autoreceptor/heteroreceptor balance in vivo, and how this balance governs antidepressant response in humans, remains unresolved.\",\n      \"evidence\": null,\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking post-translational and transcriptional control to compartment-specific receptor pools\", \"Causal human validation of autoreceptor-level effects on treatment response lacking\", \"Structural basis of region-specific G-protein selectivity unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 18, 19]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 7, 5]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 18, 19]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [3, 10, 18]}\n    ],\n    \"complexes\": [\n      \"5-HT1A homo-oligomer\",\n      \"5-HT1A/5-HT7 heterodimer\"\n    ],\n    \"partners\": [\n      \"YIF1B\",\n      \"ZDHHC21\",\n      \"HTR7\",\n      \"TRIM21\",\n      \"PSMD7\",\n      \"HES1\",\n      \"DEAF1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":8,"faith_pct":87.5}}